Product information for Hextend (6% Hetastarch in Lactated Electrolyte Inj) Cs/12
Features:
Balanced electrolyte solution that resembles the composition of the principal ionic constituents of normal plasma
Total dosage and rate of infusion depend on the amount of blood or plasma lost and the resultant hemoconcentration as well as age, weight, and clinical condition of the patient.
Volumes in excess of 1500 mL per day have been used where severe blood loss has occurred, although generally only in conjunction with the administration of blood and blood products
Completely synthetic, no risk of potential viral or prion contamination including HIV and Creutzfeldt-Jakob disease
Effective and economical alternative to 5% albumin